Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A randomized controlled trial of the clinical utility of genotypic resistance testing in patients with limited prior exposure to antiretroviral drugs.

HIV clinical trials - 1 Jan 2000

Abstract excerpt

PURPOSE: To assess the clinical utility of genotypic resistance testing among HIV-1-infected patients with limited prior exposure to antiretroviral drugs. METHOD: Patients experiencing virological failure were randomly allocated to either centralized genotypic resistance testing or to no testing and were followed for a minimum of 1 year. RESULTS: 55 patients were recruited from 14 centers in the United Kingdom....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Antiretroviral Therapy, Highly Active
Share to Drug Resistance, Multiple, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Infections

Share to Microbial Sensitivity Tests

Share to Treatment Failure

Share to United Kingdom

Source

Identifiers

PMID: 16214734
DOI: 10.1310/hct.2005.6.4.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

A randomized controlled trial of the clinical utility of genotypic resistance testing in patients with limited prior exposure to antiretroviral drugs.PMID 16214734Read ↗

A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigators.Semantic proximity Read ↗

Impact of genotypic resistance testing on physician selection of antiretroviral therapy.Semantic proximity Read ↗

HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?Semantic proximity Read ↗

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy.Semantic proximity Read ↗

Resistance tests: what do clinical trials tell us?Semantic proximity Read ↗

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.Semantic proximity Read ↗

The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach.Semantic proximity Read ↗

Genotypic antiretroviral drug resistance testing at low viral loads in the UK.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.